Thursday, 23 July 2020

Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - Latest https://ift.tt/2ORjxma
via

No comments:

Post a Comment

Lower Entry Barriers After Record Antitrust Fine: Alibaba As Shares Rally

Alibaba Group CEO Daniel Zhang said on Monday he does not expect any material impact from the change of exclusivity arrangement imposed by C...